Yüklüyor......

Proteomic cancer biomarkers from discovery to approval: it’s worth the effort

The current landscape of cancer biomarkers is changing rapidly, with new and exciting developments. With the advances of proteomic technologies, many potential cancer biomarkers have been discovered. However, the number of new cancer biomarkers cleared or approved by the US FDA is rather limited. Al...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Li, Danni, Chan, Daniel W
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4079106/
https://ncbi.nlm.nih.gov/pubmed/24646122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14789450.2014.897614
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!